Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Visceral Surgery|December 30, 2015
Leiomyosarcoma of the inferior vena cavaL Sulpice, M Rayar, G-B Levi Sandri, et al.
Human Molecular Genetics|November 1, 1993
Androgen receptor gene mutation in male breast cancerJ M Lobaccaro, S Lumbroso, C Belon, et al.
European Cytokine Network|July 21, 2000
Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancerF Bouet-Toussaint, N Genetel, N Rioux-Leclercq, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)C Rodary, V Pezet-Langevin, S Garcia-Acosta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'ImmunothérapieA Ravaud, B Audhuy, F Gomez, et al.
Bulletin Du Cancer|October 1, 1998
[Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer]P Biron, C Fuhrmann, M C Escande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II study of E7070 in patients with metastatic melanomaJ F Smyth, S Aamdal, A Awada, et al.
Presse Medicale (Paris, France : 1983)|October 25, 2000
[Standards, options and recommendations for good practice in hemoculture in cancerology]V Bussy Malgrange, M P Blanc-Vincent, M C Escande, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancerP Fumoleau, R Largillier, C Clippe, et al.
Gynecologic Oncology|October 20, 1999
A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation studyC Lhommé, P Vennin, N Callet, et al.
Pageof 5